{"id":72269,"date":"2026-08-11T12:49:11","date_gmt":"2026-08-11T04:49:11","guid":{"rendered":"https:\/\/flcube.com\/?p=72269"},"modified":"2026-08-11T12:49:12","modified_gmt":"2026-08-11T04:49:12","slug":"novo-nordisk-names-aws-preferred-cloud-provider-and-strategic-ai-partner-to-accelerate-drug-discovery-with-agentic-ai","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=72269","title":{"rendered":"Novo Nordisk Names AWS Preferred Cloud Provider and Strategic AI Partner to Accelerate Drug Discovery With Agentic AI"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Novo Nordisk (<a href=\"https:\/\/www.google.com\/finance\/beta\/quote\/NVO:NYSE\">NYSE: NVO<\/a>)<\/strong> and <strong>Amazon Web Services (AWS)<\/strong> announced a <strong>strategic partnership<\/strong> to accelerate drug discovery and modernize Novo Nordisk&#8217;s operations through <strong>agentic AI<\/strong> and cloud technologies. As part of the partnership, the two companies have created a <strong>co\u2011innovation hub in London<\/strong>, where engineers and scientists from both companies are using AWS AI technologies alongside Novo Nordisk data and insights to <strong>compress the path from drug target to first human dose<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-partnership-overview\" class=\"wp-block-heading\">Partnership Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Parties<\/strong><\/td><td>Novo Nordisk (NYSE: NVO) \u00d7 Amazon Web Services (AWS)<\/td><\/tr><tr><td><strong>Deal Type<\/strong><\/td><td>Strategic partnership<\/td><\/tr><tr><td><strong>AWS Role<\/strong><\/td><td>Preferred cloud provider and strategic AI partner<\/td><\/tr><tr><td><strong>Co\u2011Innovation Hub<\/strong><\/td><td>London \u2014 joint engineers and scientists combining AWS AI with Novo Nordisk data<\/td><\/tr><tr><td><strong>Core Objective<\/strong><\/td><td>Compress the path from drug target to first human dose<\/td><\/tr><tr><td><strong>Announcement Date<\/strong><\/td><td>10 Aug 2026<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-strategic-rationale-complementary-strengths\" class=\"wp-block-heading\">Strategic Rationale \u2013 Complementary Strengths<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The partnership brings together:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Novo Nordisk<\/th><th>AWS<\/th><\/tr><\/thead><tbody><tr><td>Deep therapeutic knowledge across chronic diseases<\/td><td>World\u2011leading cloud and AI services<\/td><\/tr><tr><td>Proprietary data and clinical insights<\/td><td>Secure and scalable infrastructure<\/td><\/tr><tr><td>Global drug development expertise<\/td><td>Life sciences technologies<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-measurable-early-results\" class=\"wp-block-heading\">Measurable Early Results<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Result<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Clinical Documentation<\/strong><\/td><td>Reduced clinical documentation time already achieved<\/td><\/tr><tr><td><strong>Workforce Empowerment<\/strong><\/td><td>More than <strong>25,000 employees<\/strong> empowered to boost productivity<\/td><\/tr><tr><td><strong>Foundation<\/strong><\/td><td>Builds on a longstanding existing relationship between the two companies<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-key-aws-technologies-deployed\" class=\"wp-block-heading\">Key AWS Technologies Deployed<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>AWS Service<\/th><th>Application<\/th><\/tr><\/thead><tbody><tr><td><strong>Amazon Bio Discovery<\/strong><\/td><td>Identify drug targets and design new therapies faster<\/td><\/tr><tr><td><strong>Amazon Bedrock<\/strong><\/td><td>Connect genomic, imaging and clinical data so early\u2011research breakthroughs can shape clinical trial design<\/td><\/tr><tr><td><strong>Amazon Bedrock AgentCore<\/strong><\/td><td>Drive efficiencies across operations through AI agents (agentic AI)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-strategic-rationale-amp-market-impact\" class=\"wp-block-heading\">Strategic Rationale &amp; Market Impact<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Target\u2011to\u2011Patient Compression:<\/strong> The London co\u2011innovation hub is explicitly designed to <strong>shorten the path from drug target to first human dose<\/strong> \u2014 a critical bottleneck in pharmaceutical R&amp;D productivity where AI\u2011driven acceleration could translate into meaningful time\u2011to\u2011market gains.<\/li>\n\n\n\n<li><strong>Agentic AI at Enterprise Scale:<\/strong> Deploying <strong>Amazon Bedrock AgentCore<\/strong> across Novo Nordisk&#8217;s operations positions the company among the first major pharma players to pursue agentic AI\u2011driven operational efficiency at the scale of 25,000+ employees.<\/li>\n\n\n\n<li><strong>Data Integration Moat:<\/strong> Connecting <strong>genomic, imaging and clinical data<\/strong> through Amazon Bedrock creates a feedback loop where early research discoveries directly inform clinical trial design \u2014 a structural advantage in chronic disease development.<\/li>\n\n\n\n<li><strong>Preferred Provider Lock\u2011In:<\/strong> By selecting AWS as its <strong>preferred cloud provider and strategic AI partner<\/strong>, Novo Nordisk consolidates its digital infrastructure on a single secure, scalable foundation \u2014 deepening a longstanding relationship into a strategic AI alliance.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding the partnership&#8217;s impact on drug discovery timelines, operational efficiency, and technology deployment. Actual results may differ due to risks including technology adoption, data integration outcomes, and regulatory considerations.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Novo Nordisk (NYSE: NVO) and Amazon Web Services (AWS) announced a strategic partnership to accelerate&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10],"tags":[99,148,860],"class_list":["post-72269","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-ai","tag-novo-nordisk","tag-nyse-nvo"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Novo Nordisk Names AWS Preferred Cloud Provider and Strategic AI Partner to Accelerate Drug Discovery With Agentic AI - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Novo Nordisk (NYSE: NVO) and Amazon Web Services (AWS) announced a strategic partnership to accelerate drug discovery and modernize Novo Nordisk&#039;s operations through agentic AI and cloud technologies. As part of the partnership, the two companies have created a co\u2011innovation hub in London, where engineers and scientists from both companies are using AWS AI technologies alongside Novo Nordisk data and insights to compress the path from drug target to first human dose.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=72269\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novo Nordisk Names AWS Preferred Cloud Provider and Strategic AI Partner to Accelerate Drug Discovery With Agentic AI\" \/>\n<meta property=\"og:description\" content=\"Novo Nordisk (NYSE: NVO) and Amazon Web Services (AWS) announced a strategic partnership to accelerate drug discovery and modernize Novo Nordisk&#039;s operations through agentic AI and cloud technologies. As part of the partnership, the two companies have created a co\u2011innovation hub in London, where engineers and scientists from both companies are using AWS AI technologies alongside Novo Nordisk data and insights to compress the path from drug target to first human dose.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=72269\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-11T04:49:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-11T04:49:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72269#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72269\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Novo Nordisk Names AWS Preferred Cloud Provider and Strategic AI Partner to Accelerate Drug Discovery With Agentic AI\",\"datePublished\":\"2026-08-11T04:49:11+00:00\",\"dateModified\":\"2026-08-11T04:49:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72269\"},\"wordCount\":463,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"AI\",\"Novo Nordisk\",\"NYSE: NVO\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=72269#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72269\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=72269\",\"name\":\"Novo Nordisk Names AWS Preferred Cloud Provider and Strategic AI Partner to Accelerate Drug Discovery With Agentic AI - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-08-11T04:49:11+00:00\",\"dateModified\":\"2026-08-11T04:49:12+00:00\",\"description\":\"Novo Nordisk (NYSE: NVO) and Amazon Web Services (AWS) announced a strategic partnership to accelerate drug discovery and modernize Novo Nordisk's operations through agentic AI and cloud technologies. As part of the partnership, the two companies have created a co\u2011innovation hub in London, where engineers and scientists from both companies are using AWS AI technologies alongside Novo Nordisk data and insights to compress the path from drug target to first human dose.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72269#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=72269\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72269#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novo Nordisk Names AWS Preferred Cloud Provider and Strategic AI Partner to Accelerate Drug Discovery With Agentic AI\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Novo Nordisk Names AWS Preferred Cloud Provider and Strategic AI Partner to Accelerate Drug Discovery With Agentic AI - Insight, China&#039;s Pharmaceutical Industry","description":"Novo Nordisk (NYSE: NVO) and Amazon Web Services (AWS) announced a strategic partnership to accelerate drug discovery and modernize Novo Nordisk's operations through agentic AI and cloud technologies. As part of the partnership, the two companies have created a co\u2011innovation hub in London, where engineers and scientists from both companies are using AWS AI technologies alongside Novo Nordisk data and insights to compress the path from drug target to first human dose.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=72269","og_locale":"en_US","og_type":"article","og_title":"Novo Nordisk Names AWS Preferred Cloud Provider and Strategic AI Partner to Accelerate Drug Discovery With Agentic AI","og_description":"Novo Nordisk (NYSE: NVO) and Amazon Web Services (AWS) announced a strategic partnership to accelerate drug discovery and modernize Novo Nordisk's operations through agentic AI and cloud technologies. As part of the partnership, the two companies have created a co\u2011innovation hub in London, where engineers and scientists from both companies are using AWS AI technologies alongside Novo Nordisk data and insights to compress the path from drug target to first human dose.","og_url":"https:\/\/flcube.com\/?p=72269","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-08-11T04:49:11+00:00","article_modified_time":"2026-08-11T04:49:12+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=72269#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=72269"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Novo Nordisk Names AWS Preferred Cloud Provider and Strategic AI Partner to Accelerate Drug Discovery With Agentic AI","datePublished":"2026-08-11T04:49:11+00:00","dateModified":"2026-08-11T04:49:12+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=72269"},"wordCount":463,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["AI","Novo Nordisk","NYSE: NVO"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=72269#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=72269","url":"https:\/\/flcube.com\/?p=72269","name":"Novo Nordisk Names AWS Preferred Cloud Provider and Strategic AI Partner to Accelerate Drug Discovery With Agentic AI - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-08-11T04:49:11+00:00","dateModified":"2026-08-11T04:49:12+00:00","description":"Novo Nordisk (NYSE: NVO) and Amazon Web Services (AWS) announced a strategic partnership to accelerate drug discovery and modernize Novo Nordisk's operations through agentic AI and cloud technologies. As part of the partnership, the two companies have created a co\u2011innovation hub in London, where engineers and scientists from both companies are using AWS AI technologies alongside Novo Nordisk data and insights to compress the path from drug target to first human dose.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=72269#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=72269"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=72269#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Novo Nordisk Names AWS Preferred Cloud Provider and Strategic AI Partner to Accelerate Drug Discovery With Agentic AI"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72269","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=72269"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72269\/revisions"}],"predecessor-version":[{"id":72270,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72269\/revisions\/72270"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=72269"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=72269"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=72269"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}